Skin Cancer

The AJMC® Skin Cancer compendium is a comprehensive resource for clinical news and expert insights about melanoma and other skin cancers.

Dr Neil Gross: Cemiplimab Is Producing Encouraging Results in Resectable cSCC

October 3rd 2022, 4:52pm


Neil D. Gross, MD, FACS, is head and neck surgeon and director of clinical research in the Department of Head and Neck Surgery at MD Anderson.

Advanced Imaging System Investigated for Faster Diagnosis of Skin Cancers

September 30th 2022, 6:15pm


This new study explored the diagnostic utility and accuracy of 2-photon fluorescence microscopy (TPFM) among nonmelanoma skin cancers, which included basal cell carcinoma and squamous cell carcinoma.

Postsurgical Positive Margins Top Indicator of BCC Recurrence

September 27th 2022, 8:42pm


This new study investigated risk factors for basal cell carcinoma (BCC) recurrence in the head and neck region.

Dermoscopy Holds Limited Potential to Differentiate BCC From Benign Tumors

September 24th 2022, 2:10pm


Despite some differences in the frequency of dermoscopic features between basal cell carcinoma (BCC) and benign skin tumors, dermoscopy alone is not sufficient for a reliable diagnosis, according to a recent study.

Squamous, Basal Cell Carcinoma Top Skin Cancers Among Persons With Albino Skin

September 19th 2022, 7:33pm


Previous study results on incidence of skin cancers in persons with albino skin who live in Africa have been inconsistent, despite this population having a known higher risk for the disease.

Dr Igor Puzanov Discusses the State of Adjuvant Therapy for Advanced Melanoma

September 12th 2022, 9:46pm


In this interview with The American Journal of Managed Care® (AJMC®), Igor Puzanov, MD, of Roswell Park Comprehensive Cancer Center and Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, discusses the state of treatment selection in the setting of resected advanced melanoma, why sequencing of therapies does not occur in the setting of adjuvant therapy, and best practices to keep in mind for patient education and managing their treatment-related toxicities.

More Study Needed on Melanoma Risk From Methotrexate

September 7th 2022, 6:49pm


Quantifying the risk of malignant melanoma from methotrexate use proved difficult in this new study, with the authors calling for larger studies with longer follow-up to guide future practice in the space.

Dermoscopy May Be More Accurate vs Incisional Biopsy for Melanoma Thickness

August 31st 2022, 7:24pm


In this new study, investigators searched for potential predictors of melanoma thickness, with implications for treatment decisions regarding biopsy and excision margins.

Dr Sigrun Hallmeyer Highlights Clinical Achievements and Barriers in Melanoma

August 24th 2022, 6:21pm


In this interview with The American Journal of Managed Care®, Sigrun Hallmeyer, MD, medical director of Advocate Lutheran General Hospital’s Cancer Service Line and co-director of medical research at Advocate Aurora Health, in Illinois, touches on several important topics within the melanoma space.

Skin Cancer Knowledge Suboptimal Among Patients

August 17th 2022, 9:33pm


Adult patients from dermatology clinics affiliated with 2 Midwest universities were evaluated for their ability to differentiate skin cancer by sight and for their skin cancer knowledge.